Jacobi Capital Management’s Sana Biotechnology SANA Stock Holding History

Jacobi Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.9K	Hold	10,000	–	–	﹤0.01%	644
2026 Q1	$28.8K	Hold	10,000	–	–	﹤0.01%	631
2025 Q4	$40.7K	Buy	+10,000	New	+$44.8K	﹤0.01%	608
2021 Q4	–	Sell	-100	Closed	-$2K	–	1139
2021 Q3	$2K	Hold	100	–	–	﹤0.01%	1337
2021 Q2	$2K	Hold	100	–	–	﹤0.01%	1280
2021 Q1	$3K	Buy	+100	New	+$3.26K	﹤0.01%	1214

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jacobi Capital Management's SANA Position: Q2 2026 in Review

Jacobi Capital Management held its Sana Biotechnology (SANA) position steady in Q2 2026 at 10,000 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Jacobi Capital Management first reported a position in SANA in Q1 2021 and has held it in 6 quarters since. The position peaked at $40.7K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Jacobi Capital Management held 10,000 shares of Sana Biotechnology worth $34.9K as of Q2 2026.
Jacobi Capital Management left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Jacobi Capital Management's portfolio in Q2 2026, its #644 holding.
Jacobi Capital Management first reported a position in Sana Biotechnology in Q1 2021 and has held it in 6 quarters since.
Jacobi Capital Management's Sana Biotechnology position peaked at $40.7K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.